Novocure Ltd. (NVCR) Social Stream
NOVOCURE LTD (NVCR) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NOVOCURE LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 7 | $200 | $85 | $151.5 | $58.45 | 159.2% |
| 2022-01-03 | 8 | $200 | $82 | $141.571 | $58.45 | 142.21% |
| 2022-01-06 | 8 | $200 | $82 | $134.428 | $58.45 | 129.99% |
| 2022-01-11 | 8 | $200 | $45 | $112.285 | $58.45 | 92.1% |
| 2022-01-20 | 8 | $200 | $45 | $112.285 | $58.45 | 92.1% |
| 2022-02-02 | 9 | $200 | $45 | $110.5 | $58.45 | 89.05% |
| 2022-02-08 | 9 | $200 | $45 | $120.444 | $58.45 | 106.06% |
| 2022-02-25 | 9 | $200 | $45 | $114.777 | $58.45 | 96.37% |
| 2022-05-08 | 9 | $200 | $45 | $114.333 | $58.45 | 95.61% |
| 2022-05-13 | 9 | $200 | $45 | $111.555 | $58.45 | 90.86% |
| 2022-06-06 | 10 | $200 | $45 | $111.9 | $58.45 | 91.45% |
| 2022-07-11 | 9 | $200 | $45 | $113.444 | $58.45 | 94.09% |
| 2022-07-29 | 9 | $200 | $45 | $110.111 | $58.45 | 88.38% |
| 2022-08-02 | 7 | $200 | $45 | $98.875 | $58.45 | 69.16% |
| 2022-10-24 | 7 | $200 | $45 | $96.375 | $58.45 | 64.88% |
| 2022-10-28 | 7 | $200 | $45 | $94.125 | $58.45 | 61.04% |
| 2022-11-29 | 8 | $200 | $43 | $96.25 | $58.45 | 64.67% |
| 2022-12-06 | 8 | $200 | $43 | $96.125 | $58.45 | 64.46% |
| 2022-12-22 | 8 | $200 | $43 | $96.5 | $58.45 | 65.1% |
| 2023-01-06 | 8 | $200 | $65 | $107.428 | $58.45 | 83.79% |
| 2023-01-12 | 8 | $200 | $65 | $111.142 | $58.45 | 90.15% |
| 2023-01-17 | 8 | $200 | $65 | $112.571 | $58.45 | 92.59% |
| 2023-02-23 | 7 | $130 | $65 | $97.166 | $58.45 | 66.24% |
The Trend in the Analyst Price Target
NVCR's average price target has moved down $94.83 over the prior 19 months.
NVCR reports an average of 34.08% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-06 | 8 | 200 | 43 | 96.125 | 73.48 | 30.82% |
| 2022-12-22 | 8 | 200 | 43 | 96.500 | 79.78 | 20.96% |
| 2022-12-22 | 8 | 200 | 43 | 98.571 | 79.78 | 23.55% |
| 2023-01-06 | 8 | 200 | 65 | 111.857 | 109.04 | 2.58% |
| 2023-01-12 | 8 | 200 | 65 | 111.142 | 95.70 | 16.14% |
NVCR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 2 | 0 | 3 | 2 | 2 | 7 |
The Trend in the Broker Recommendations
NVCR's average broker recommendation rating worsened by 1.25 over the prior 35 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, NOVOCURE LTD's variance in analysts' estimates is lower than -2643.87% of them.
- NOVOCURE LTD's number of analysts covering the stock is higher than 550.68% of stocks in the large market cap category.
- NOVOCURE LTD's upside potential (average analyst target price relative to current price) is greater than 2409.24% of stocks in the large market cap category.
- NVCR has a higher average analyst price target than 2391.62% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to NOVOCURE LTD are PODD, DXCM, and RMD.
View All Top Stocks by Price Target
Is NVCR a Buy, Hold or Sell? See the POWR Ratings now!